FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3021603185> ?p ?o ?g. }

• W3021603185 endingPage "317" @default.
• W3021603185 startingPage "316" @default.
• W3021603185 abstract "BACKGROUND: Early recovery is an important factor for people undergoing facial plastic. However, the normal inflammatory processes that are a consequence of surgery commonly cause oedema (swelling) and ecchymosis (bruising), which are undesirable complications. Severe oedema and ecchymosis delay full recovery, and may make patients dissatisfied with procedures. Perioperative corticosteroids have been used in facial plastic surgery with the aim of preventing oedema and ecchymosis. OBJECTIVES: To determine the effects, including safety, of perioperative administration of corticosteroids for preventing complications following facial plastic surgery in adults. METHODS: Search strategy: In January 2014, we searched the following electronic databases: the Cochrane Wounds Group Specialised Register; the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library); Ovid MEDLINE; Ovid MEDLINE (In-Process & Other Non-Indexed Citations); Ovid Embase; EBSCO CINAHL; and Literatura Latino-Americana e do Caribe em Ciências da Saúde (LILACS). There were no restrictions on the basis of date or language of publication. Selection criteria: We included RCTs that compared the administration of perioperative systemic corticosteroids with another intervention, no intervention or placebo in facial plastic surgery. ata collection and analysis: Two review authors independently screened the trials for inclusion in the review, appraised trial quality and extracted data. MAIN RESULTS: We included 10 trials, with a total of 422 participants, that addressed two of the outcomes of interest to this review: swelling (oedema) and bruising (ecchymosis). Nine studies on rhinoplasty used a variety of different types, and doses, of corticosteroids. Overall, the results of the included studies showed that there is some evidence that perioperative administration of corticosteroids decreases formation of oedema over the first two postoperative days. Meta-analysis was only possible for two studies, with a total of 60 participants, and showed that a single perioperative dose of 10 mg dexamethasone decreased oedema formation in the first two days after surgery (SMD = -1.16, 95% CI: -1.71 to -0.61, low quality evidence). The evidence for ecchymosis was less consistent across the studies, with some contradictory results, but overall there was some evidence that perioperatively administered corticosteroids decreased ecchymosis formation over the first two days after surgery (SMD = -1.06, 95% CI:-1.47 to -0.65, two studies, 60 participants, low quality evidence). The difference was not maintained after this initial period. One study, with 40 participants, showed that high doses of methylprednisolone (over 250 mg) decreased both ecchymosis and oedema between the first and seventh postoperative days. The only study that assessed facelift surgery identified no positive effect on oedema with preoperative administration of corticosteroids. Five trials did not report on harmful (adverse) effects; four trials reported that there were no adverse effects; and one trial reported adverse effects in two participants treated with corticosteroids as well as in four participants treated with placebo. None of the studies reported recovery time, patient satisfaction or quality of life. The studies included were all at an unclear risk of selection bias and at low risk of bias for other domains. AUTHORS' CONCLUSIONS: There is limited evidence for rhinoplasty that a single perioperative dose of corticosteroids decreases oedema and ecchymosis formation over the first two postoperative days, but the difference is not maintained after this period. There is also limited evidence that high doses of corticosteroids decrease both ecchymosis and oedema between the first and seventh postoperative days. The clinical significance of this decrease is unknown and there is little evidence available regarding the safety of this intervention. More studies are needed because at present the available evidence does not support the use of corticosteroids for prevention of complications following facial plastic surgery." @default.
• W3021603185 created "2020-05-13" @default.
• W3021603185 creator A5008594783 @default.
• W3021603185 creator A5018061572 @default.
• W3021603185 creator A5031306590 @default.
• W3021603185 date "2014-01-01" @default.
• W3021603185 modified "2023-10-16" @default.
• W3021603185 title "Perioperative corticosteroids for preventing complications following facial plastic surgery" @default.
• W3021603185 cites W2027581811 @default.
• W3021603185 cites W2070092209 @default.
• W3021603185 cites W2326776544 @default.
• W3021603185 doi "https://doi.org/10.1590/1516-3180.20141325t2" @default.
• W3021603185 hasPublicationYear "2014" @default.
• W3021603185 type Work @default.
• W3021603185 sameAs 3021603185 @default.
• W3021603185 citedByCount "1" @default.
• W3021603185 countsByYear W30216031852017 @default.
• W3021603185 crossrefType "journal-article" @default.
• W3021603185 hasAuthorship W3021603185A5008594783 @default.
• W3021603185 hasAuthorship W3021603185A5018061572 @default.
• W3021603185 hasAuthorship W3021603185A5031306590 @default.
• W3021603185 hasBestOaLocation W30216031851 @default.
• W3021603185 hasConcept C141071460 @default.
• W3021603185 hasConcept C142724271 @default.
• W3021603185 hasConcept C168563851 @default.
• W3021603185 hasConcept C17744445 @default.
• W3021603185 hasConcept C199539241 @default.
• W3021603185 hasConcept C204787440 @default.
• W3021603185 hasConcept C27081682 @default.
• W3021603185 hasConcept C2776478404 @default.
• W3021603185 hasConcept C2779473830 @default.
• W3021603185 hasConcept C2779663748 @default.
• W3021603185 hasConcept C31174226 @default.
• W3021603185 hasConcept C71924100 @default.
• W3021603185 hasConceptScore W3021603185C141071460 @default.
• W3021603185 hasConceptScore W3021603185C142724271 @default.
• W3021603185 hasConceptScore W3021603185C168563851 @default.
• W3021603185 hasConceptScore W3021603185C17744445 @default.
• W3021603185 hasConceptScore W3021603185C199539241 @default.
• W3021603185 hasConceptScore W3021603185C204787440 @default.
• W3021603185 hasConceptScore W3021603185C27081682 @default.
• W3021603185 hasConceptScore W3021603185C2776478404 @default.
• W3021603185 hasConceptScore W3021603185C2779473830 @default.
• W3021603185 hasConceptScore W3021603185C2779663748 @default.
• W3021603185 hasConceptScore W3021603185C31174226 @default.
• W3021603185 hasConceptScore W3021603185C71924100 @default.
• W3021603185 hasIssue "5" @default.
• W3021603185 hasLocation W30216031851 @default.
• W3021603185 hasLocation W30216031852 @default.
• W3021603185 hasOpenAccess W3021603185 @default.
• W3021603185 hasPrimaryLocation W30216031851 @default.
• W3021603185 hasRelatedWork W1996551696 @default.
• W3021603185 hasRelatedWork W2078130225 @default.
• W3021603185 hasRelatedWork W2112324575 @default.
• W3021603185 hasRelatedWork W2112468425 @default.
• W3021603185 hasRelatedWork W2149347908 @default.
• W3021603185 hasRelatedWork W2414366497 @default.
• W3021603185 hasRelatedWork W2999349737 @default.
• W3021603185 hasRelatedWork W3031564866 @default.
• W3021603185 hasRelatedWork W4321437654 @default.
• W3021603185 hasRelatedWork W4360608871 @default.
• W3021603185 hasVolume "132" @default.
• W3021603185 isParatext "false" @default.
• W3021603185 isRetracted "false" @default.
• W3021603185 magId "3021603185" @default.
• W3021603185 workType "article" @default.